SIGACHI37.60

Sigachi Industries Limited

· Pharma & Health
₹ CrorePeersLINCOLNTHEMISMEDBAJAJHCAREAMRUTANJANJAGSNPHARMWANBURYNGLFINEMcap ₹1,437 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Total Debt143.1142.2135.6135.6
Net Debt125.6124.9114.7114.7
Total Debt/Equity0.320.230.260.26
Net Debt/Equity0.280.200.220.22
Total Debt/EBITDA1.871.422.522.52
Net Debt/EBITDA1.641.252.132.48
Interest Coverage (EBIT/Interest)8.486.782.602.60
Total Debt/Total Capital %24.4918.8220.4020.40
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.